Bill Text: OR SB1506 | 2012 | Regular Session | Amended

NOTE: There are more recent revisions of this legislation. Read Latest Draft

---

Bill Title: Relating to mental health drugs; and declaring an emergency.

Sponsorship: Unknown

Status: (Passed) 2012-03-20 - Effective date, March 16, 2012. [SB1506 Detail]

Download: Oregon-2012-SB1506-Amended.html

---

     76th OREGON LEGISLATIVE ASSEMBLY--2012 Regular Session

SA to SB 1506

LC 181/SB 1506-4

                      SENATE AMENDMENTS TO
                        SENATE BILL 1506

  By COMMITTEE ON HEALTH CARE, HUMAN SERVICES AND RURAL HEALTH
                             POLICY

                           February 14

  On page 1 of the printed bill, delete lines 4 through 28 and
delete page 2.
  On page 3, delete lines 1 through 23 and insert:
  '  { +  SECTION 1. + }  { + (1) The Central Oregon Health
Council shall appoint a Mental Health Clinical Advisory Group to
establish voluntary evidence-based treatment algorithms for the
treatment of major mental health disorders. The advisory group
shall consider all of the following:
  ' (a) The extent to which sufficient clinical evidence exists
to support a treatment algorithm.
  ' (b) Peer-reviewed medical literature.
  ' (c) Observational studies.
  ' (d) Studies of health economics.
  ' (e) Input from patients and physicians.
  ' (f) Other information deemed by the advisory group to be
appropriate.
  ' (2) The Mental Health Clinical Advisory Group must include,
at a minimum, all of the following:
  ' (a) Two community psychiatrists.
  ' (b) One child and adolescent psychiatrist.
  ' (c) Two licensed clinical psychologists.
  ' (d) One licensed clinical social worker.
  ' (e) One psychiatric nurse practitioner.
  ' (f) Two primary care providers.
  ' (g) Two pharmacists, including one pharmacist who supplies
long-term care facilities and special needs clients.
  ' (h) Two representatives of statewide mental health advocacy
organizations for children and adults who live with mental
illness, with preference given to individuals with personal
experience with mental illness.
  ' (3) The Mental Health Clinical Advisory Group must:
  ' (a) Be independent from any agency of state government;
  ' (b) Be provided with a meeting space, staffing,
telecommunications and necessary materials and supplies by the
Central Oregon Health Council; and
  ' (c) Post agendas, minutes and a recording of advisory group
meetings no later than five days after each meeting.
  ' (4) The affirmative votes of a majority of the Mental Health
Clinical Advisory Group's members are required before the
advisory group takes action on any measure, treatment algorithm
or recommendation.
  ' (5) The Mental Health Clinical Advisory Group shall
investigate and make recommendations for implementation of the
following:
  ' (a) An academic detailing program in which retrospective
claims data are used to educate prescribers on the cost and
quality implications of their prescribing patterns;

  ' (b) A program providing low-cost, prepackaged medication
samples to prescribers for distribution to patients free of
charge;
  ' (c) A medication therapy management services program carried
out by pharmacists licensed in this state that is targeted to
individuals with mental health conditions, and that is designed
to increase shared decision-making between patients and
prescribers, improve consumer understanding of medications,
promote person-directed care, improve medication adherence and
prevent complications, drug interactions, inappropriate
discontinuation or other adverse outcomes;
  ' (d) A program using voluntary psychiatric clinical treatment
algorithms developed by the advisory group; and
  ' (e) Clinical prescribing programs that include:
  ' (A) Clinical, economic and quality of life targets.
  ' (B) Intervention with medical providers, behavioral health
providers and the patient or patient's caregiver to promote
person-directed care, improve health and quality of life outcomes
and improve prescribing practices.
  ' (C) Using all antidepressants and antipsychotic medications,
and any psychiatric medication that is approved by the United
States Food and Drug Administration, as preferred medications on
any formulary.
  ' (6) Incentives or education may be provided to promote any of
the programs identified in subsection (5)(a) to (d) of this
section so long as the incentives or education are not designed
to encourage prescribers to change medications or substitute
medications for patients who are stabilized on or are currently
responding to and tolerating a medication.
  ' (7) The Mental Health Clinical Advisory Group shall report
annually to the appropriate committees of the Legislative
Assembly related to health care on its review and recommendations
for prescribing practices, the implementation of clinical
programs and any associated clinical, economic and quality of
life outcomes of the program.
  ' (8) No later than July 1, 2012, the Oregon Health Authority
shall provide to the managed care organization supporting the
Central Oregon Health Council pharmacy claims data to support the
work of the Mental Health Clinical Advisory Group. The authority
shall supply the data in a format agreed to by the authority and
the council. + } ' .
                         ----------